Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process.
benign gynecologic disease
consensus study
fertility preservation
modified Delphi method
oocyte vitrification
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Aug 2021
25 Aug 2021
Historique:
received:
04
07
2021
revised:
04
08
2021
accepted:
18
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification-in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.
Identifiants
pubmed: 34501257
pii: jcm10173810
doi: 10.3390/jcm10173810
pmc: PMC8432013
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Clin Endocrinol Metab. 2013 Feb;98(2):729-35
pubmed: 23316087
Hum Reprod. 2015 Aug;30(8):1974-81
pubmed: 26082477
Hum Reprod Update. 2014 May-Jun;20(3):370-85
pubmed: 24430863
Hum Reprod Open. 2020 Nov 16;2020(4):hoaa046
pubmed: 33225075
Gynecol Obstet Fertil Senol. 2018 Mar;46(3):368-372
pubmed: 29530556
Fertil Steril. 2016 Feb;105(2):459-66.e2
pubmed: 26604065
J Clin Oncol. 2018 Jul 1;36(19):1994-2001
pubmed: 29620997
Pediatr Endocrinol Rev. 2019 Mar;16(3):369-382
pubmed: 30888127
PLoS One. 2011;6(6):e20476
pubmed: 21694759
Hum Reprod. 2019 Oct 2;34(10):1855-1857
pubmed: 31553798
Cochrane Database Syst Rev. 2020 Oct 23;10:CD011031
pubmed: 33095458
Fertil Steril. 2016 Mar;105(3):603-604
pubmed: 26773193
Fertil Steril. 2020 Apr;113(4):836-844
pubmed: 32145929
J Visc Surg. 2018 Jun;155 Suppl 1:S31-S36
pubmed: 29709485
Hum Reprod Open. 2019 Jun 12;2019(3):hoz009
pubmed: 31206037
Hum Reprod. 2018 Dec 1;33(12):2222-2231
pubmed: 30383235
N Engl J Med. 2010 Jun 24;362(25):2389-98
pubmed: 20573927
Fertil Steril. 2020 Apr;113(4):765-766
pubmed: 32147176
J Minim Invasive Gynecol. 2020 Feb;27(2):362-372
pubmed: 31546067
J Pediatr Adolesc Gynecol. 2016 Oct;29(5):409-416
pubmed: 26485320
Thromb Haemost. 2018 Nov;118(11):1962-1968
pubmed: 30296817
Reprod Biomed Online. 2011 Sep;23(3):334-40
pubmed: 21775211
South Med J. 2018 Apr;111(4):187-191
pubmed: 29719026
Hum Reprod Open. 2020 Nov 14;2020(4):hoaa052
pubmed: 33225079
Dan Med J. 2016 Oct;63(10):
pubmed: 27697140